Molecular characterization and antifungal susceptibilitytesting of Candida nivariensis from blood samples – an Iranian multicentre study and a review of the literature

Autor: Sadegh Khodavaisy, Carlo Brouwer, Farnaz Daneshnia, Amir Arastehfar, Teun Boekhout, Mohammad-Javad Najafzadeh, Kamiar Zomorodian, Maryam Roudbary, Ferry Hagen, Pieter-Jan A. Haas, Hossein Zarrinfar, Arezoo Charsizadeh, Mohammadreza Salehi, Weihua Pan
Přispěvatelé: Evolutionary and Population Biology (IBED, FNWI)
Jazyk: angličtina
Rok vydání: 2019
Předmět:
0301 basic medicine
Male
Antifungal Agents
Iran
Bronchoalveolar Lavage
Polymerase Chain Reaction
chemistry.chemical_compound
Fatal Outcome
Caspofungin
Amplified Fragment Length Polymorphism Analysis
Fluconazole
Fluconazole/pharmacology
Candida
Vagina/microbiology
Voriconazole/pharmacology
Broth microdilution
Candidiasis
General Medicine
Middle Aged
3. Good health
Vagina
Antifungal Agents/pharmacology
DNA
Intergenic

Female
medicine.drug
Microbiology (medical)
Adolescent
Genotype
030106 microbiology
Candidemia/diagnosis
Microbial Sensitivity Tests
Biology
Microbiology
03 medical and health sciences
Amphotericin B/pharmacology
Candida/drug effects
Caspofungin/pharmacology
Amphotericin B
medicine
Humans
Matrix-Assisted Laser Desorption-Ionization
Genotyping
Aged
Voriconazole
Intergenic
Candida glabrata
Spectrometry
Micafungin
Candidemia
DNA
Mass
biology.organism_classification
bacterial infections and mycoses
Candidiasis/blood
030104 developmental biology
chemistry
Spectrometry
Mass
Matrix-Assisted Laser Desorption-Ionization

Anidulafungin
Zdroj: Journal of Medical Microbiology, 68(5), 770-777. Society for General Microbiology
Journal of Medical Microbiology
ISSN: 0022-2615
Popis: Purpose. Identification of the emerging yeast species Candida nivariensis among presumptively identified Iranian Candida glabrata isolates. Methodology. Clinical C. glabrata species complex isolates from blood (n=100; 46.9%), vaginal swabs (n=20; 9.4%), bronchoalveolar lavage (n=10; 4.7%) and sputum (n=12; 5.6%) from 68 patients from Iran were investigated. Isolates were characterized by CHROMagar, multiplex PCRs, matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS), amplified fragment length polymorphism (AFLP) fingerprinting, internal transcribed spacer (ITS)/large subunit (LSU) rDNA and FKS1/FKS2 sequencing, and the European Committee on Antimicrobial Susceptibility Testing broth microdilution method. A comprehensive literature review was conducted and all the relevant clinical and microbiological data were collected.Results. Four C. nivariensis isolates were recovered from blood samples of three subjects and were all consistently identified by nine-plex PCR, Bruker MALDI-TOF MS, and LSU and ITS rDNA sequencing. AFLP genotyping clustered the isolates into two groups. Sequencing of the FKS1 and FKS2 hotspots showed no accountable amino acid substitutions. All isolates were susceptible to amphotericin B, fluconazole, itraconazole, posaconazole, voriconazole, anidulafungin and micafungin.Conclusion. In total, 4 out of 213 clinical C. glabrata species complex candidemia isolates were C. nivariensis. Improvement of the BioMerieux Vitek MS database is required to accurately identify C. nivariensis and it is advised to alternatively use CHROMagar and/or PCR-based techniques. As other species within the Nakaseomyces clade may cause infection and showed high MIC values for antifungals, inclusion of their spectra into the MALDI-TOF MS database seems relevant. Due to developing resistance to fluconazole and insufficient efficacy of caspofungin, the combination of catheter removal plus treatment with caspofungin, or voriconazole, or micafungin might be effective for patients.
Databáze: OpenAIRE